BPMC
Loomis, Sayles & Company’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-325,815
| Closed | -$21.5M | – | 871 |
|
|
2022
Q3 | $21.5M | Sell |
325,815
-3,945
| -1% | -$260K | 0.04% | 205 |
|
|
2022
Q2 | $16.7M | Sell |
329,760
-108,262
| -25% | -$5.47M | 0.03% | 274 |
|
|
2022
Q1 | $28M | Buy |
438,022
+58,923
| +16% | +$3.76M | 0.04% | 241 |
|
|
2021
Q4 | $40.6M | Sell |
379,099
-10,229
| -3% | -$1.1M | 0.05% | 195 |
|
|
2021
Q3 | $40M | Sell |
389,328
-6,040
| -2% | -$621K | 0.05% | 199 |
|
|
2021
Q2 | $34.8M | Sell |
395,368
-8,034
| -2% | -$707K | 0.04% | 229 |
|
|
2021
Q1 | $39.2M | Buy |
403,402
+48,011
| +14% | +$4.67M | 0.05% | 192 |
|
|
2020
Q4 | $39.9M | Sell |
355,391
-2,097
| -0.6% | -$235K | 0.05% | 164 |
|
|
2020
Q3 | $33.1M | Buy |
357,488
+48,289
| +16% | +$4.48M | 0.05% | 158 |
|
|
2020
Q2 | $24.1M | Buy |
+309,199
| New | +$24.1M | 0.04% | 191 |
|
|
2020
Q1 | – | Sell |
-426,978
| Closed | -$34.2M | – | 727 |
|
|
2019
Q4 | $34.2M | Sell |
426,978
-12,302
| -3% | -$986K | 0.06% | 126 |
|
|
2019
Q3 | $32.3M | Buy |
439,280
+64,012
| +17% | +$4.7M | 0.06% | 130 |
|
|
2019
Q2 | $35.4M | Buy |
375,268
+4,501
| +1% | +$425K | 0.07% | 126 |
|
|
2019
Q1 | $29.7M | Buy |
370,767
+13,372
| +4% | +$1.07M | 0.06% | 135 |
|
|
2018
Q4 | $19.3M | Buy |
357,395
+273,142
| +324% | +$14.7M | 0.05% | 177 |
|
|
2018
Q3 | $6.58M | Buy |
+84,253
| New | +$6.58M | 0.01% | 446 |
|